Joinn Laboratories (06127) nominates Yang Fuquan, Yang Changyun, and Ying Fangtian as independent non-executive directors respectively.

Joint Laboratories (06127) announced that the Board of Directors recently received resignation letters from Mr. Sun Mingcheng (Mr. Sun), Dr. Zhai Yonggong (Dr. Zhai), and Mr. Ou Xiaojie (Mr. Ou). Mr. Sun, Dr. Zhai, and Mr. Ou resigned from their positions as independent non-executive directors after serving continuously for nearly six years. The resignations will take effect after the appointment of new independent non-executive directors is approved by the shareholders at the upcoming extraordinary general meeting. Upon their resignation, Mr. Sun will no longer serve as the Chairman of the Audit Committee and member of the Remuneration and Appraisal Committee; Dr. Zhai will no longer serve as Chairman of the Nomination Committee and member of the Audit Committee; and Mr. Ou will no longer serve as Chairman of the Remuneration and Appraisal Committee and member of the Nomination Committee and Strategy Development Committee. The Board of Directors also received a resignation letter from Mr. Zuo Conglin (Mr. Zuo) recently. Mr. Zuo resigned from his position as an executive director mainly due to work arrangements. Upon his resignation, Mr. Zuo will no longer serve as the Vice Chairman of the Board, and member of the Remuneration and Appraisal Committee and Strategy Development Committee. The Board of Directors decided to nominate Mr. Yang Fuquan, Mr. Yang Changyun, and Mr. Ying Fangtian as independent non-executive directors. The appointment of Mr. Yang Fuquan, Mr. Yang Changyun, and Mr. Ying Fangtian as independent non-executive directors is subject to approval by the shareholders at the extraordinary general meeting through an ordinary resolution. The Board of Directors decided to nominate Mr. Gu Jingliang as an executive director. The appointment of Mr. Gu Jingliang as an executive director is subject to approval by the shareholders at the extraordinary general meeting.